Director/PDMR Shareholding -

RNS Number : 5157B
GlaxoSmithKline PLC
28 October 2009
 



This announcement replaces the original announcement released on 12 October 2009 at 15.23 (RNS No: 6307A)


The Company was notified by its Registrars on 27 October 2009 of a correction to the dividend reinvestment for Mr S A Hussain. The number of ordinary shares purchased on behalf of Mr Hussain should have read 3 Ordinary shares under the Dividend Reinvestment element of the Plan.  This was due to an administrative error by the Registrars.


Save as disclosed above, all other details remain unchanged.


Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons



I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.34 per Ordinary share on 8 October 2009 through the Company's ShareReward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:


Mr A P Witty

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr J S Heslop

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr S M Bicknell

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr E J Gray

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr S A Hussain

Acquisition of 3 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr D Learmouth

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Dr D Pulman

Acquisition of 9 Ordinary shares under the Dividend Reinvestment element of the Plan


Mr D S Redfern

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan


Ms C Thomas

Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan



The Company and the above-mentioned persons were advised of this information on 12 October 2009.


This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).



V A Whyte

Deputy Company Secretary

12 October 2009



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGMZGZRVGLZM

Companies

GSK (GSK)
UK 100

Latest directors dealings